Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives-Reference-Cited by-同舟云学术

Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives

Published:2022-06 Issue: Volume:236 Page:114326
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhang Jinfeng,Luo Ziwei,Duan Wenwen^ORCID,Yang Kexin,Ling Lijun,Yan Wenzhong,Liu Ruiquan,Wüthrich Kurt,Jiang Hualiang,Xie Chengying,Cheng Jianjun^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference27 articles.

1. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine;Blay;Cancer Res.,1997

2. Tumor immunotherapy using A2A adenosine receptor antagonists;Zhang;Pharmaceuticals,2020

3. Targeting immunosuppressive adenosine in cancer;Vijayan;Nat. Rev. Cancer,2017

4. International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update;Fredholm;Pharmacol. Rev.,2011

5. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage;Ohta;Nature,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Peptide‐Nanoplatform Drives Oncoimmune Response and Reverses Adenosine‐Induced Immunosuppressive Tumor Microenvironment;Advanced Healthcare Materials;2024-07-09

2. Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential;Archiv der Pharmazie;2024-05-16

3. Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A2A adenosine receptors and histone deacetylases;Chinese Chemical Letters;2024-01

4. A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy;European Journal of Medicinal Chemistry;2023-11

5. Pharmacology of Adenosine Receptors: Recent Advancements;Biomolecules;2023-09-14